COSCIENS Biopharma Statistics
Total Valuation
CSCIF has a market cap or net worth of 6.39 million. The enterprise value is -92,866.
| Market Cap | 6.39M |
| Enterprise Value | -92,866 |
Important Dates
The next estimated earnings date is Wednesday, March 25, 2026.
| Earnings Date | Mar 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 3.18M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +30.54% |
| Shares Change (QoQ) | +0.07% |
| Owned by Insiders (%) | 0.55% |
| Owned by Institutions (%) | 0.00% |
| Float | 2.92M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.71 |
| PB Ratio | 1.26 |
| P/TBV Ratio | 1.26 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 0.01 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 0.01 |
Financial Position
The company has a current ratio of 3.47, with a Debt / Equity ratio of 0.43.
| Current Ratio | 3.47 |
| Quick Ratio | 2.54 |
| Debt / Equity | 0.43 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.20 |
| Interest Coverage | -47.69 |
Financial Efficiency
Return on equity (ROE) is -118.80% and return on invested capital (ROIC) is -131.40%.
| Return on Equity (ROE) | -118.80% |
| Return on Assets (ROA) | -14.01% |
| Return on Invested Capital (ROIC) | -131.40% |
| Return on Capital Employed (ROCE) | -38.15% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | 226,350 |
| Profits Per Employee | -372,650 |
| Employee Count | 40 |
| Asset Turnover | 0.27 |
| Inventory Turnover | 1.99 |
Taxes
In the past 12 months, CSCIF has paid 1.08 million in taxes.
| Income Tax | 1.08M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.41% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -27.41% |
| 50-Day Moving Average | 2.12 |
| 200-Day Moving Average | 2.88 |
| Relative Strength Index (RSI) | 45.72 |
| Average Volume (20 Days) | 1,159 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, CSCIF had revenue of 9.05 million and -14.91 million in losses. Loss per share was -4.73.
| Revenue | 9.05M |
| Gross Profit | 4.01M |
| Operating Income | -7.58M |
| Pretax Income | -13.82M |
| Net Income | -14.91M |
| EBITDA | -6.63M |
| EBIT | -7.58M |
| Loss Per Share | -4.73 |
Balance Sheet
The company has 8.52 million in cash and 2.17 million in debt, with a net cash position of 6.35 million.
| Cash & Cash Equivalents | 8.52M |
| Total Debt | 2.17M |
| Net Cash | 6.35M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 5.08M |
| Book Value Per Share | 1.60 |
| Working Capital | 9.85M |
Cash Flow
In the last 12 months, operating cash flow was -10.00 million and capital expenditures -969,000, giving a free cash flow of -10.97 million.
| Operating Cash Flow | -10.00M |
| Capital Expenditures | -969,000 |
| Free Cash Flow | -10.97M |
| FCF Per Share | n/a |
Margins
Gross margin is 44.30%, with operating and profit margins of -83.74% and -164.63%.
| Gross Margin | 44.30% |
| Operating Margin | -83.74% |
| Pretax Margin | -152.68% |
| Profit Margin | -164.63% |
| EBITDA Margin | -73.27% |
| EBIT Margin | -83.74% |
| FCF Margin | n/a |
Dividends & Yields
CSCIF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -30.54% |
| Shareholder Yield | -30.54% |
| Earnings Yield | -233.17% |
| FCF Yield | -171.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on May 3, 2024. It was a reverse split with a ratio of 0.25.
| Last Split Date | May 3, 2024 |
| Split Type | Reverse |
| Split Ratio | 0.25 |
Scores
CSCIF has an Altman Z-Score of -1 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -1 |
| Piotroski F-Score | 4 |